| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Secretary | President And CEO | Director
3 companies
Holubiak Myron Z is a President And CEO at Citius Pharmaceuticals, Inc. with holdings across 3 companies. Recent SEC Form 4 filings include 4 buys and 0 sells.
Estimated insider holdings value: $2.3M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 27, 2019 | CTXR Citius Pharmaceuticals, Inc. | President And CEO | Buy | 558,597 | $0.90 | $500,000.17 | +39.0% | |
| Apr 3, 2019 | CTXR Citius Pharmaceuticals, Inc. | President And CEO | Buy | 129,450 | $1.55 | $200,000.25 | +9.9% | |
| Aug 13, 2018 | CTXR Citius Pharmaceuticals, Inc. | President And CEO | Buy | 784,314 | $1.28 | $1,000,000.35 | +150.9% | |
| Mar 28, 2018 | CTXR Citius Pharmaceuticals, Inc. | President And CEO | Buy | 2,915 | $3.09 | $9,007.35 | +0.6% |